Adenocarcinoma of the Pancreas Completed Phase 1 Trials for Sorafenib (DB00398)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00375310Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic CancerTreatment